Debra A. Peattie

Private Equity Investor chez SV Investment Corp/US/

Profil

Debra A. Peattie founded Valeo Medical, Inc. in 2003, where she worked as Chief Technology Officer from 2003 to 2009.
Dr. Peattie also currently works at SV Investment Corp, as Managing Partner from 2022.
Dr. Peattie also formerly worked at Epiphany Biosciences, Inc., as Director, GSK Plc, as Senior Director from 2013 to 2019, Harvard University, as Director-Business Development from 2011 to 2013, Office of Technology Development, as Director, Inhibitor Therapeutics, Inc., as Independent Director from 2019 to 2022, Valo Health LLC, as Executive director from 2019 to 2022, Cubist Pharmaceuticals LLC, as Principal, MPM BioImpact, Inc, as Principal, RCT BioVentures, as Principal, Harvard T.H.
Chan School of Public Health, as Professor, and RCT BioVentures NE LLC, as President from 1999 to 2003.
Dr. Peattie received her doctorate degree from Harvard University, undergraduate degree from Hollins University Corp., and Masters Business Admin degree from Harvard Business School.

Postes actifs de Debra A. Peattie

Sociétés	Poste	Début
SV Investment Corp/US/	Private Equity Investor	01/01/2022

Anciens postes connus de Debra A. Peattie

Sociétés	Poste	Fin
HEDGEPATH PHARMACEUTICALS INC	Directeur/Membre du Conseil	01/06/2022
Valo Health LLC	Private Equity Investor	01/01/2022
GSK PLC	Private Equity Investor	01/01/2019
Harvard University	Corporate Officer/Principal	01/01/2013
Valeo Medical, Inc.	Fondateur	03/11/2009